<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">35045161</PMID><DateCompleted><Year>2022</Year><Month>09</Month><Day>16</Day></DateCompleted><DateRevised><Year>2022</Year><Month>10</Month><Day>09</Day></DateRevised><Article PubModel="Print"><Journal><ISSN IssnType="Electronic">1460-2156</ISSN><JournalIssue CitedMedium="Internet"><Volume>145</Volume><Issue>9</Issue><PubDate><Year>2022</Year><Month>Sep</Month><Day>14</Day></PubDate></JournalIssue><Title>Brain : a journal of neurology</Title><ISOAbbreviation>Brain</ISOAbbreviation></Journal><ArticleTitle>Mutation in senataxin alters the mechanism of R-loop resolution in amyotrophic lateral sclerosis 4.</ArticleTitle><Pagination><StartPage>3072</StartPage><EndPage>3094</EndPage><MedlinePgn>3072-3094</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1093/brain/awab464</ELocationID><Abstract><AbstractText>Mutation in the senataxin (SETX) gene causes an autosomal dominant neuromuscular disorder, amyotrophic lateral sclerosis 4 (ALS4), characterized by degeneration of motor neurons, muscle weakness and atrophy. SETX is an RNA-DNA helicase that mediates resolution of co-transcriptional RNA:DNA hybrids (R-loops). The process of R-loop resolution is essential for the normal functioning of cells, including neurons. The molecular basis of ALS4 pathogenesis and the mechanism of R-loop resolution are unclear. We report that the zinc finger protein ZPR1 binds to RNA:DNA hybrids, recruits SETX onto R-loops and is critical for R-loop resolution. ZPR1 deficiency disrupts the integrity of R-loop resolution complexes containing SETX and causes increased R-loop accumulation throughout gene transcription. We uncover that SETX is a downstream target of ZPR1 and that overexpression of ZPR1 can rescue R-loop resolution complexe assembly in SETX-deficient cells but not vice versa. To uncover the mechanism of R-loop resolution, we examined the function of SETX-ZPR1 complexes using two genetic motor neuron disease models with altered R-loop resolution. Notably, chronic low levels of SETX-ZPR1 complexes onto R-loops result in a decrease of R-loop resolution activity causing an increase in R-loop levels in spinal muscular atrophy. ZPR1 overexpression increases recruitment of SETX onto R-loops, decreases R-loops and rescues the spinal muscular atrophy phenotype in motor neurons and patient cells. Strikingly, interaction of SETX with ZPR1 is disrupted in ALS4 patients that have heterozygous SETX (L389S) mutation. ZPR1 fails to recruit the mutant SETX homodimer but recruits the heterodimer with partially disrupted interaction between SETX and ZPR1. Interestingly, disruption of SETX-ZPR1 complexes causes increase in R-loop resolution activity leading to fewer R-loops in ALS4. Modulation of ZPR1 levels regulates R-loop accumulation and rescues the pathogenic R-loop phenotype in ALS4 patient cells. These findings originate a new concept, 'opposite alterations in a cell biological activity (R-loop resolution) result in similar pathogenesis (neurodegeneration) in different genetic motor neuron disorders'. We propose that ZPR1 collaborates with SETX and may function as a molecular brake to regulate SETX-dependent R-loop resolution activity critical for the normal functioning of motor neurons.</AbstractText><CopyrightInformation>&#xa9; The Author(s) 2022. Published by Oxford University Press on behalf of the Guarantors of Brain.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kannan</LastName><ForeName>Annapoorna</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Center of Emphasis in Neurosciences, Texas Tech University Health Sciences Center El Paso, El Paso, TX 79905, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Molecular and Translational Medicine, Paul L. Foster School of Medicine, Texas Tech University Health Sciences Center El Paso, El Paso, TX 79905, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cuartas</LastName><ForeName>Juliana</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Center of Emphasis in Neurosciences, Texas Tech University Health Sciences Center El Paso, El Paso, TX 79905, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Molecular and Translational Medicine, Paul L. Foster School of Medicine, Texas Tech University Health Sciences Center El Paso, El Paso, TX 79905, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gangwani</LastName><ForeName>Pratik</ForeName><Initials>P</Initials><Identifier Source="ORCID">0000-0002-9205-9119</Identifier><AffiliationInfo><Affiliation>Automated Driving Compute System Architecture, GM Global Technical Center - Sloan Engineering Center, Warren, MI 48092, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Branzei</LastName><ForeName>Dana</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>The FIRC Institute of Molecular Oncology Foundation, IFOM Foundation, Milan 20139, Italy.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Istituto di Genetica Molecolare, Consiglio Nazionale delle Ricerche (IGM-CNR), 27100 Pavia, Italy.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gangwani</LastName><ForeName>Laxman</ForeName><Initials>L</Initials><Identifier Source="ORCID">0000-0001-8575-9937</Identifier><AffiliationInfo><Affiliation>Center of Emphasis in Neurosciences, Texas Tech University Health Sciences Center El Paso, El Paso, TX 79905, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Molecular and Translational Medicine, Paul L. Foster School of Medicine, Texas Tech University Health Sciences Center El Paso, El Paso, TX 79905, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>R01 NS064224</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant><Grant><GrantID>R01 NS115834</GrantID><Acronym>NS</Acronym><Agency>NINDS NIH HHS</Agency><Country>United States</Country></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D052061">Research Support, N.I.H., Extramural</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Brain</MedlineTA><NlmUniqueID>0372537</NlmUniqueID><ISSNLinking>0006-8950</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D064251">Multifunctional Enzymes</NameOfSubstance></Chemical><Chemical><RegistryNumber>63231-63-0</RegistryNumber><NameOfSubstance UI="D012313">RNA</NameOfSubstance></Chemical><Chemical><RegistryNumber>9007-49-2</RegistryNumber><NameOfSubstance UI="D004247">DNA</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.6.1.-</RegistryNumber><NameOfSubstance UI="C484368">SETX protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.6.4.-</RegistryNumber><NameOfSubstance UI="D004265">DNA Helicases</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.6.4.13</RegistryNumber><NameOfSubstance UI="D020365">RNA Helicases</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="Y">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004247" MajorTopicYN="N">DNA</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004265" MajorTopicYN="Y">DNA Helicases</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D064251" MajorTopicYN="Y">Multifunctional Enzymes</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009134" MajorTopicYN="N">Muscular Atrophy, Spinal</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009154" MajorTopicYN="N">Mutation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000080870" MajorTopicYN="N">R-Loop Structures</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012313" MajorTopicYN="N">RNA</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D020365" MajorTopicYN="Y">RNA Helicases</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">DNA damage response</Keyword><Keyword MajorTopicYN="N">R-loops</Keyword><Keyword MajorTopicYN="N">ZPR1</Keyword><Keyword MajorTopicYN="N">amyotrophic lateral sclerosis 4</Keyword><Keyword MajorTopicYN="N">spinal muscular atrophy</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2021</Year><Month>9</Month><Day>20</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2021</Year><Month>11</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2021</Year><Month>12</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2022</Year><Month>1</Month><Day>20</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2022</Year><Month>9</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2022</Year><Month>1</Month><Day>19</Day><Hour>19</Hour><Minute>31</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">35045161</ArticleId><ArticleId IdType="pmc">PMC9536298</ArticleId><ArticleId IdType="doi">10.1093/brain/awab464</ArticleId><ArticleId IdType="pii">6511590</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Chance PF, Rabin BA, Ryan SG, et al. . Linkage of the gene for an autosomal dominant form of juvenile amyotrophic lateral sclerosis to chromosome 9q34. Am J Hum Genet 1998;62:633&#x2013;640.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1376963</ArticleId><ArticleId IdType="pubmed">9497266</ArticleId></ArticleIdList></Reference><Reference><Citation>Rabin BA, Griffin JW, Crain BJ, Scavina M, Chance PF, Cornblath DR. Autosomal dominant juvenile amyotrophic lateral sclerosis. Brain 1999;122(Pt 8):1539&#x2013;1550.</Citation><ArticleIdList><ArticleId IdType="pubmed">10430837</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y-Z, Bennett CL, Huynh HM, et al. . DNA/RNA helicase gene mutations in a form of juvenile amyotrophic lateral sclerosis (ALS4). Am J Hum Genet 2004;74:1128&#x2013;1135.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1182077</ArticleId><ArticleId IdType="pubmed">15106121</ArticleId></ArticleIdList></Reference><Reference><Citation>Groh M, Albulescu LO, Cristini A, Gromak N. Senataxin: Genome Guardian at the Interface of Transcription and Neurodegeneration. J Mol Biol 2017;429:3181&#x2013;3195.</Citation><ArticleIdList><ArticleId IdType="pubmed">27771483</ArticleId></ArticleIdList></Reference><Reference><Citation>Crossley MP, Bocek M, Cimprich KA. R-loops as cellular regulators and genomic threats. Mol Cell 2019;73:398&#x2013;411.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6402819</ArticleId><ArticleId IdType="pubmed">30735654</ArticleId></ArticleIdList></Reference><Reference><Citation>Costantino L, Koshland D. Genome-wide map of r-loop-induced damage reveals how a subset of R-loops contributes to genomic instability. Mol Cell 2018;71:487&#x2013;497.e3.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6264797</ArticleId><ArticleId IdType="pubmed">30078723</ArticleId></ArticleIdList></Reference><Reference><Citation>Skourti-Stathaki K, Proudfoot NJ. A double-edged sword: R loops as threats to genome integrity and powerful regulators of gene expression. Genes Dev 2014;28:1384&#x2013;96.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4083084</ArticleId><ArticleId IdType="pubmed">24990962</ArticleId></ArticleIdList></Reference><Reference><Citation>Wells JP, White J, Stirling PC. R loops and their composite cancer connections. Trends Cancer 2019;5:619&#x2013;631.</Citation><ArticleIdList><ArticleId IdType="pubmed">31706509</ArticleId></ArticleIdList></Reference><Reference><Citation>Richard P, Manley JL. R loops and links to human disease. J Mol Biol 2017;429:3168&#x2013;3180.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5478472</ArticleId><ArticleId IdType="pubmed">27600412</ArticleId></ArticleIdList></Reference><Reference><Citation>Garcia-Muse T, Aguilera A. R loops: from physiological to pathological roles. Cell 2019;179:604&#x2013;618.</Citation><ArticleIdList><ArticleId IdType="pubmed">31607512</ArticleId></ArticleIdList></Reference><Reference><Citation>Sollier J, Cimprich KA. Breaking bad: R-loops and genome integrity. Trends Cell Biol 2015;25:514&#x2013;522.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4554970</ArticleId><ArticleId IdType="pubmed">26045257</ArticleId></ArticleIdList></Reference><Reference><Citation>Allison DF, Wang GG. R-loops: formation, function, and relevance to cell stress. Cell Stress 2019;3:38&#x2013;46.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6551709</ArticleId><ArticleId IdType="pubmed">31225499</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhatia V, Herrera-Moyano E, Aguilera A, Gomez-Gonzalez B. The role of replication-associated repair factors on R-loops. Genes (Basel) 2017;8:171.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5541304</ArticleId><ArticleId IdType="pubmed">28653981</ArticleId></ArticleIdList></Reference><Reference><Citation>Cristini A, Groh M, Kristiansen MS, Gromak N. RNA/DNA hybrid interactome identifies DXH9 as a molecular player in transcriptional termination and R-loop-associated DNA damage. Cell Rep 2018;23:1891&#x2013;1905.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5976580</ArticleId><ArticleId IdType="pubmed">29742442</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang IX, Grunseich C, Fox J, et al. . Human proteins that interact with RNA/DNA hybrids. Genome Res 2018;28:1405&#x2013;1414.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6120628</ArticleId><ArticleId IdType="pubmed">30108179</ArticleId></ArticleIdList></Reference><Reference><Citation>Skourti-Stathaki K, Proudfoot NJ, Gromak N. Human senataxin resolves RNA/DNA hybrids formed at transcriptional pause sites to promote Xrn2-dependent termination. Mol Cell 2011;42:794&#x2013;805.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3145960</ArticleId><ArticleId IdType="pubmed">21700224</ArticleId></ArticleIdList></Reference><Reference><Citation>Cohen S, Puget N, Lin Y-L, et al. . Senataxin resolves RNA:DNA hybrids forming at DNA double-strand breaks to prevent translocations. Nat Commun 2018;9:533.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5803260</ArticleId><ArticleId IdType="pubmed">29416069</ArticleId></ArticleIdList></Reference><Reference><Citation>Mischo HE, G&#xf3;mez-Gonz&#xe1;lez B, Grzechnik P, et al. . Yeast Sen1 helicase protects the genome from transcription-associated instability. Mol Cell 2011;41:21&#x2013;32.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3314950</ArticleId><ArticleId IdType="pubmed">21211720</ArticleId></ArticleIdList></Reference><Reference><Citation>Rawal CC, Zardoni L, Di Terlizzi M, et al. . Senataxin ortholog Sen1 limits DNA:RNA hybrid accumulation at DNA double-strand breaks to control end resection and repair fidelity. Cell Rep 2020;31:107603.</Citation><ArticleIdList><ArticleId IdType="pubmed">32375052</ArticleId></ArticleIdList></Reference><Reference><Citation>Chakraborty P, Huang JTJ, Hiom K. DHX9 helicase promotes R-loop formation in cells with impaired RNA splicing. Nat Commun 2018;9:4346.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6195550</ArticleId><ArticleId IdType="pubmed">30341290</ArticleId></ArticleIdList></Reference><Reference><Citation>Suraweera A, Lim Y, Woods R, et al. . Functional role for senataxin, defective in ataxia oculomotor apraxia type 2, in transcriptional regulation. Hum Mol Genet 2009;18:3384&#x2013;3396.</Citation><ArticleIdList><ArticleId IdType="pubmed">19515850</ArticleId></ArticleIdList></Reference><Reference><Citation>Ursic D, Chinchilla K, Finkel JS, Culbertson MR. Multiple protein/protein and protein/RNA interactions suggest roles for yeast DNA/RNA helicase Sen1p in transcription, transcription-coupled DNA repair and RNA processing. Nucleic Acids Res 2004;32:2441&#x2013;2452.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC419450</ArticleId><ArticleId IdType="pubmed">15121901</ArticleId></ArticleIdList></Reference><Reference><Citation>Yuce O, West SC. Senataxin, defective in the neurodegenerative disorder ataxia with oculomotor apraxia 2, lies at the interface of transcription and the DNA damage response. Mol Cell Biol 2013;33:406&#x2013;417.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3554130</ArticleId><ArticleId IdType="pubmed">23149945</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao DY, Gish G, Braunschweig U, et al. . SMN and symmetric arginine dimethylation of RNA polymerase II C-terminal domain control termination. Nature 2016;529(7584):48&#x2013;53.</Citation><ArticleIdList><ArticleId IdType="pubmed">26700805</ArticleId></ArticleIdList></Reference><Reference><Citation>Lefebvre S, Burglen L, Reboullet S, et al. . Identification and characterization of a spinal muscular atrophy- determining gene. Cell 1995;80:155&#x2013;165.</Citation><ArticleIdList><ArticleId IdType="pubmed">7813012</ArticleId></ArticleIdList></Reference><Reference><Citation>Kannan A, Bhatia K, Branzei D, Gangwani L. Combined deficiency of Senataxin and DNA-PKcs causes DNA damage accumulation and neurodegeneration in spinal muscular atrophy. Nucleic Acids Res 2018;46:8326&#x2013;8346.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6144794</ArticleId><ArticleId IdType="pubmed">30010942</ArticleId></ArticleIdList></Reference><Reference><Citation>Gangwani L, Flavell RA, Davis RJ. ZPR1 is essential for survival and is required for localization of the survival motor neurons (SMN) protein to Cajal bodies. Mol Cell Biol 2005;25:2744&#x2013;2756.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1061650</ArticleId><ArticleId IdType="pubmed">15767679</ArticleId></ArticleIdList></Reference><Reference><Citation>Gangwani L, Mikrut M, Galcheva-Gargova Z, Davis RJ. Interaction of ZPR1 with translation elongation factor-1alpha in proliferating cells. J Cell Biol 1998;143:1471&#x2013;1484.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2132977</ArticleId><ArticleId IdType="pubmed">9852145</ArticleId></ArticleIdList></Reference><Reference><Citation>Galcheva-Gargova Z, Gangwani L, Konstantinov KN, et al. . The cytoplasmic zinc finger protein ZPR1 accumulates in the nucleolus of proliferating cells. Mol Biol Cell 1998;9:2963&#x2013;2971.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC25573</ArticleId><ArticleId IdType="pubmed">9763455</ArticleId></ArticleIdList></Reference><Reference><Citation>Mishra AK, Gangwani L, Davis RJ, Lambright DG. Structural insights into the interaction of the evolutionarily conserved ZPR1 domain tandem with eukaryotic EF1A, receptors, and SMN complexes. Proc Natl Acad Sci U S A 2007;104:13930&#x2013;13935.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1955815</ArticleId><ArticleId IdType="pubmed">17704259</ArticleId></ArticleIdList></Reference><Reference><Citation>Gangwani L, Mikrut M, Theroux S, Sharma M, Davis RJ. Spinal muscular atrophy disrupts the interaction of ZPR1 with the SMN protein. Nat Cell Biol 2001;3:376&#x2013;383.</Citation><ArticleIdList><ArticleId IdType="pubmed">11283611</ArticleId></ArticleIdList></Reference><Reference><Citation>Kannan A, Jiang X, He L, Ahmad S, Gangwani L. ZPR1 prevents R-loop accumulation, upregulates SMN2 expression and rescues spinal muscular atrophy. Brain 2020;143:69&#x2013;93.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6935747</ArticleId><ArticleId IdType="pubmed">31828288</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmad S, Wang Y, Shaik GM, Burghes AH, Gangwani L. The zinc finger protein ZPR1 is a potential modifier of spinal muscular atrophy. Hum Mol Genet 2012;21:2745&#x2013;2758.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3363332</ArticleId><ArticleId IdType="pubmed">22422766</ArticleId></ArticleIdList></Reference><Reference><Citation>Doran B, Gherbesi N, Hendricks G, Flavell RA, Davis RJ, Gangwani L. Deficiency of the zinc finger protein ZPR1 causes neurodegeneration. Proc Natl Acad Sci U S A 2006;103:7471&#x2013;7475.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1464363</ArticleId><ArticleId IdType="pubmed">16648254</ArticleId></ArticleIdList></Reference><Reference><Citation>Genabai NK, Kannan A, Ahmad S, Jiang X, Bhatia K, Gangwani L. Deregulation of ZPR1 causes respiratory failure in spinal muscular atrophy. Sci Rep 2017;7:8295.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5557895</ArticleId><ArticleId IdType="pubmed">28811488</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahmad S, Bhatia K, Kannan A, Gangwani L. Molecular mechanisms of neurodegeneration in spinal muscular atrophy. J Exp Neurosci 2016;10:39&#x2013;49.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4807884</ArticleId><ArticleId IdType="pubmed">27042141</ArticleId></ArticleIdList></Reference><Reference><Citation>Le TT, Pham LT, Butchbach ME, et al. . SMNDelta7, the major product of the centromeric survival motor neuron (SMN2) gene, extends survival in mice with spinal muscular atrophy and associates with full-length SMN. Hum Mol Genet 2005;14:845&#x2013;857.</Citation><ArticleIdList><ArticleId IdType="pubmed">15703193</ArticleId></ArticleIdList></Reference><Reference><Citation>Grunseich C, Wang IX, Watts JA, et al. . Senataxin mutation reveals how R-loops promote transcription by blocking DNA nethylation at gene promoters. Mol Cell 2018;69:426&#x2013;437.e7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5815878</ArticleId><ArticleId IdType="pubmed">29395064</ArticleId></ArticleIdList></Reference><Reference><Citation>Gangwani L. Deficiency of the zinc finger protein ZPR1 causes defects in transcription and cell cycle progression. J Biol Chem 2006;281:40330&#x2013;40340.</Citation><ArticleIdList><ArticleId IdType="pubmed">17068332</ArticleId></ArticleIdList></Reference><Reference><Citation>Genabai NK, Ahmad S, Zhang Z, Jiang X, Gabaldon CA, Gangwani L. Genetic inhibition of JNK3 ameliorates spinal muscular atrophy. Hum Mol Genet 2015;24:6986&#x2013;7004.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4654054</ArticleId><ArticleId IdType="pubmed">26423457</ArticleId></ArticleIdList></Reference><Reference><Citation>Boguslawski SJ, Smith DE, Michalak MA, et al. . Characterization of monoclonal antibody to DNA&#xb7;RNA and its application to immunodetection of hybrids. J Immunol Methods 1986;89:123&#x2013;130.</Citation><ArticleIdList><ArticleId IdType="pubmed">2422282</ArticleId></ArticleIdList></Reference><Reference><Citation>Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2&#x2212;&#x394;&#x394;CT Method. Methods 2001;25:402&#x2013;408.</Citation><ArticleIdList><ArticleId IdType="pubmed">11846609</ArticleId></ArticleIdList></Reference><Reference><Citation>Gangwani L, Khurana JP, Maheshwari SC. Inhibition of chloroplast protein phosphorylation by cAMP in Lemna paucicostata 6746. Phytochemistry 1996;41:49&#x2013;54.</Citation></Reference><Reference><Citation>Ausubel FM, Brent R, Kingston RE, et al., eds. Enzymatic Manipulation of DNA and RNA: Ribonucleases. Current Protocols in Molecular Biology. John Wiley &amp; Sons, Inc.; 2006.</Citation></Reference><Reference><Citation>Halasz L, Karanyi Z, Boros-Olah B, et al. . RNA-DNA hybrid (R-loop) immunoprecipitation mapping: an analytical workflow to evaluate inherent biases. Genome Res 2017;27:1063&#x2013;1073.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5453320</ArticleId><ArticleId IdType="pubmed">28341774</ArticleId></ArticleIdList></Reference><Reference><Citation>Makharashvili N, Arora S, Yin Y, et al. . Sae2/CtIP prevents R-loop accumulation in eukaryotic cells. Elife 2018;7:e42733.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6296784</ArticleId><ArticleId IdType="pubmed">30523780</ArticleId></ArticleIdList></Reference><Reference><Citation>Sollier J, Stork CT, Garcia-Rubio ML, Paulsen RD, Aguilera A, Cimprich KA. Transcription-coupled nucleotide excision repair factors promote R-loop-induced genome instability. Mol Cell 2014;56:777&#x2013;785.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4272638</ArticleId><ArticleId IdType="pubmed">25435140</ArticleId></ArticleIdList></Reference><Reference><Citation>Galcheva-Gargova Z, Konstantinov KN, Wu IH, Klier FG, Barrett T, Davis RJ. Binding of zinc finger protein ZPR1 to the epidermal growth factor receptor. Science 1996;272(5269):1797&#x2013;1802.</Citation><ArticleIdList><ArticleId IdType="pubmed">8650580</ArticleId></ArticleIdList></Reference><Reference><Citation>Stork CT, Bocek M, Crossley MP, et al. . Co-transcriptional R-loops are the main cause of estrogen-induced DNA damage. Elife 2016;5:e17548.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5030092</ArticleId><ArticleId IdType="pubmed">27552054</ArticleId></ArticleIdList></Reference><Reference><Citation>Bennett CL, La Spada AR. Senataxin, A Novel Helicase at the Interface of RNA Transcriptome Regulation and Neurobiology: From Normal Function to Pathological Roles in Motor Neuron Disease and Cerebellar Degeneration. Adv Neurobiol 2018;20:265&#x2013;281.</Citation><ArticleIdList><ArticleId IdType="pubmed">29916023</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown TA, Tkachuk AN, Clayton DA. Native R-loops persist throughout the mouse mitochondrial DNA genome. J Biol Chem 2008;283:36743&#x2013;36751.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2605977</ArticleId><ArticleId IdType="pubmed">18986989</ArticleId></ArticleIdList></Reference><Reference><Citation>Konig F, Schubert T, Langst G. The monoclonal S9.6 antibody exhibits highly variable binding affinities towards different R-loop sequences. PLoS One 2017;12:e0178875.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5464589</ArticleId><ArticleId IdType="pubmed">28594954</ArticleId></ArticleIdList></Reference><Reference><Citation>Phillips DD, Garboczi DN, Singh K, Hu Z, Leppla SH, Leysath CE. The sub-nanomolar binding of DNA-RNA hybrids by the single-chain Fv fragment of antibody S9.6. J Mol Recognit 2013;26:376&#x2013;381.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4061737</ArticleId><ArticleId IdType="pubmed">23784994</ArticleId></ArticleIdList></Reference><Reference><Citation>Smolka JA, Sanz LA, Hartono SR, Ch&#xe9;din F. Recognition of RNA by the S9.6 antibody creates pervasive artifacts when imaging RNA:DNA hybrids. J Cell Biol 2021;220:e202004079.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8040515</ArticleId><ArticleId IdType="pubmed">33830170</ArticleId></ArticleIdList></Reference><Reference><Citation>Jangi M, Fleet C, Cullen P, et al. . SMN deficiency in severe models of spinal muscular atrophy causes widespread intron retention and DNA damage. Proc Natl Acad Sci U S A 2017;114:E2347&#x2013;E2356.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5373344</ArticleId><ArticleId IdType="pubmed">28270613</ArticleId></ArticleIdList></Reference><Reference><Citation>Helmken C, Hofmann Y, Schoenen F, et al. . Evidence for a modifying pathway in SMA discordant families: reduced SMN level decreases the amount of its interacting partners and Htra2-beta1. Hum Genet 2003;114:11&#x2013;21.</Citation><ArticleIdList><ArticleId IdType="pubmed">14520560</ArticleId></ArticleIdList></Reference><Reference><Citation>Bennett CL, Chen Y, Vignali M, et al. . Protein interaction analysis of senataxin and the ALS4 L389S mutant yields insights into senataxin post-translational modification and uncovers mutant-specific binding with a brain cytoplasmic RNA-encoded peptide. PLoS One 2013;8:e78837.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3823977</ArticleId><ArticleId IdType="pubmed">24244371</ArticleId></ArticleIdList></Reference><Reference><Citation>Fogel BL, Cho E, Wahnich A, et al. . Mutation of senataxin alters disease-specific transcriptional networks in patients with ataxia with oculomotor apraxia type 2. Hum Mol Genet 2014;23:4758&#x2013;4769.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4140459</ArticleId><ArticleId IdType="pubmed">24760770</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang X, Kannan A, Gangwani L. ZPR1-Dependent Neurodegeneration Is Mediated by the JNK Signaling Pathway. J Exp Neurosci 2019;13:1179069519867915.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6709431</ArticleId><ArticleId IdType="pubmed">31488953</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Z, Lotti F, Dittmar K, et al. . SMN deficiency causes tissue-specific perturbations in the repertoire of snRNAs and widespread defects in splicing. Cell 2008;133:585&#x2013;600.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2446403</ArticleId><ArticleId IdType="pubmed">18485868</ArticleId></ArticleIdList></Reference><Reference><Citation>Merkhofer EC, Hu P, Johnson TL. Introduction to cotranscriptional RNA splicing. Methods Mol Biol 2014;1126:83&#x2013;96.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4102251</ArticleId><ArticleId IdType="pubmed">24549657</ArticleId></ArticleIdList></Reference><Reference><Citation>Paulsen RD, Soni DV, Wollman R, et al. . A genome-wide siRNA screen reveals diverse cellular processes and pathways that mediate genome stability. Mol Cell 2009;35:228&#x2013;239.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC2772893</ArticleId><ArticleId IdType="pubmed">19647519</ArticleId></ArticleIdList></Reference><Reference><Citation>Kornblihtt AR, de la Mata M, Fededa JP, Munoz MJ, Nogues G. Multiple links between transcription and splicing. RNA 2004;10:1489&#x2013;1498.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1370635</ArticleId><ArticleId IdType="pubmed">15383674</ArticleId></ArticleIdList></Reference><Reference><Citation>Becherel OJ, Sun J, Yeo AJ, et al. . A new model to study neurodegeneration in ataxia oculomotor apraxia type 2. Hum Mol Genet 2015;24:5759&#x2013;5774.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4581605</ArticleId><ArticleId IdType="pubmed">26231220</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang EY-C, Novoa CA, Aristizabal MJ, et al. . RECQ-like helicases Sgs1 and BLM regulate R-loop&#x2013;associated genome instability. J Cell Biol 2017;216:3991&#x2013;4005.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5716281</ArticleId><ArticleId IdType="pubmed">29042409</ArticleId></ArticleIdList></Reference><Reference><Citation>Madireddy A, Kosiyatrakul ST, Boisvert RA, et al. . FANCD2 Facilitates replication through common fragile sites. Mol Cell 2016;64:388&#x2013;404.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5683400</ArticleId><ArticleId IdType="pubmed">27768874</ArticleId></ArticleIdList></Reference><Reference><Citation>Liang Z, Liang F, Teng Y, et al. . Binding of FANCI-FANCD2 complex to RNA and R-loops stimulates robust FANCD2 monoubiquitination. Cell Rep 2019;26:564&#x2013;572.e5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6350941</ArticleId><ArticleId IdType="pubmed">30650351</ArticleId></ArticleIdList></Reference><Reference><Citation>Villarreal OD, Mersaoui SY, Yu Z, Masson JY, Richard S. Genome-wide R-loop analysis defines unique roles for DDX5, XRN2, and PRMT5 in DNA/RNA hybrid resolution. Life Sci Alliance 2020;3:e202000762.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7409538</ArticleId><ArticleId IdType="pubmed">32747416</ArticleId></ArticleIdList></Reference><Reference><Citation>Onichtchouk D, Chen Y-G, Dosch R, et al. . Silencing of TGF-&#x3b2; signalling by the pseudoreceptor BAMBI. Nature 1999;401(6752):480&#x2013;485.</Citation><ArticleIdList><ArticleId IdType="pubmed">10519551</ArticleId></ArticleIdList></Reference><Reference><Citation>Colavita A, Krishna S, Zheng H, Padgett RW, Culotti JG. Pioneer axon guidance by UNC-129, a C. elegans TGF-beta. Science 1998;281(5377):706&#x2013;709.</Citation><ArticleIdList><ArticleId IdType="pubmed">9685266</ArticleId></ArticleIdList></Reference><Reference><Citation>Martinou J-C, Le Van Thai A, Valette A, Weber MJ. Transforming growth factor &#x3b2;1 is a potent survival factor for rat embryo motoneurons in culture. Brain Res Dev Brain Res 1990;52(1-2):175&#x2013;181.</Citation><ArticleIdList><ArticleId IdType="pubmed">2331786</ArticleId></ArticleIdList></Reference><Reference><Citation>Endo F, Komine O, Fujimori-Tonou N, et al. . Astrocyte-derived TGF- &#x3b2;1 accelerates disease progression in ALS mice by interfering with the neuroprotective functions of microglia and T cells. Cell Rep 2015;11:592&#x2013;604.</Citation><ArticleIdList><ArticleId IdType="pubmed">25892237</ArticleId></ArticleIdList></Reference><Reference><Citation>Houi K, Kobayashi T, Kato S, Mochio S, Inoue K. Increased plasma TGF-&#x3b2;1 in patients with amyotrophic lateral sclerosis. Acta Neurol Scand 2002;106:299&#x2013;301.</Citation><ArticleIdList><ArticleId IdType="pubmed">12371924</ArticleId></ArticleIdList></Reference><Reference><Citation>Phatnani HP, Guarnieri P, Friedman BA, et al. . Intricate interplay between astrocytes and motor neurons in ALS. Proc Natl Acad Sci U S A 2013;110:E756&#x2013;E765.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3581928</ArticleId><ArticleId IdType="pubmed">23388633</ArticleId></ArticleIdList></Reference><Reference><Citation>Bennett CL, Dastidar SG, Ling S-C, et al. . Senataxin mutations elicit motor neuron degeneration phenotypes and yield TDP-43 mislocalization in ALS4 mice and human patients. Acta Neuropathol 2018;136:425&#x2013;443.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6098723</ArticleId><ArticleId IdType="pubmed">29725819</ArticleId></ArticleIdList></Reference><Reference><Citation>Corcia P, Couratier P, Blasco H, et al. . Genetics of amyotrophic lateral sclerosis. Rev Neurol 2017;173:254&#x2013;262.</Citation><ArticleIdList><ArticleId IdType="pubmed">28449881</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>